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Background:  Cardiac sarcoidosis (CS) may manifest as fatal ventricular arrhythmias. Rubidium-Fluorodeoxyglucose Positron Emission Tomography 
(Rb-FDG PET) has been proposed for the diagnosis of CS. We hypothesized that specific abnormal imaging patterns by Rb-FDG PET would associate 
with various arrhythmias in patients (pts) with CS.
Methods:  In total, 55 consecutive pts seen at our institution in 2009-2011 fulfilling Japanese Ministry of Health and Welfare (JMHW) criteria 
for CS were evaluated with Rb-FDG PET imaging. Each of the 17 standard myocardial segments was categorized as: normal, metabolism-perfusion 
matched defect consistent with scar, or metabolism-perfusion mismatch defect consistent with inflammation. All pts had undergone cardiac 
catheterization to exclude significant obstructive coronary disease.
Results:  Of the 55 pts, a total of 37 pts (67%) had sustained ventricular tachycardia (VT). All 37 pts with VT had an abnormal Rb-FDG PET study 
(p=0.03). Among pts with VT, mean left ventricular involvement by inflammation was 12%; mean left ventricular involvement by scar was 10%; and 
ejection fraction 34%. In pts demonstrating scar or inflammation in ≥2 basal or mid septal segments, 83% had VT (p<0.04). Among those with 
inflammation only (n=15), 80% had VT (p=0.13). However if inflammation involved the basal septal regions, VT was present in all subjects (n=7, 
p=0.05). Among pts with basal anteroseptal segment inflammation, 80% had significant conduction disease defined as bifascicular, trifascicular or 
complete heart block (p=0.04).
Conclusions:  In pts with JMHW criteria for CS, the presence of VT and/or significant conduction system disease appears related to the anatomic 
site of disease involvement, as defined by Rb-FDG PET imaging. Future prospective clinical studies are needed to determine if PET imaging is helpful 
in identifying CS pts at risk for VT and/or high grade conduction abnormalities.
